Todd Giorgio

Prof. Todd Giorgio

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1993 in Annals of Surgery
Verified
Journal Article
Closed access
JRJacek Rozga
Jacek Rozga
MHMichael D. Holzman
Michael D. Holzman
MRMan-Soo Ro
Man-Soo Ro
DGDonald W. Griffin
Donald W. Griffin
DNDaniel F. Neuzil
Daniel F. Neuzil
ADAchilles A. Demetriou
Achilles A. Demetriou
The authors developed an extracorporeal liver support system and tested its efficacy in experimental animals with liver failure. The first clinical use of this system to treat a patient with liver failure is reported. Multiple attempts have been made, ranging from plasma exchange to use of charcoal columns, to develop liver support systems for treating patients with acute severe liver failure. None of these systems has achieved wide clinical use. There is a need for providing liver support as a "bridge" to transplantation and for treating patients with potentially reversible liver dysfunction. A hybrid liver support system has been developed consisting of plasma perfusion through a charcoal column and a porous hollow fiber module inoculated with 5 x 10(9) matrix-attached hepatocytes. The system was tested in dogs with ischemic liver failure (n = 7) who underwent plasmapheresis; a control group (n = 6) underwent charcoal perfusion alone. A patient with liver failure was treated with this hybrid system. After 6 hours of hybrid liver support treatment, animals had significantly decreased serum ammonia and lactate levels, increased glucose level, normal prothrombin time, and increased systolic blood pressure compared with controls treated with charcoal perfusion alone. Use of the system to treat a patient was well tolerated with evidence of clinical improvement. Plasma perfusion through a system consisting of a charcoal column and matrix-attached porcine hepatocytes had significant beneficial effects in animals with liver failure and was well tolerated by a patient with liver failure.

12 February 2013 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
SYShann S. Yu
Shann S. Yu
CLCheryl M. Lau
Cheryl M. Lau
WBWhitney J. Barham
Whitney J. Barham
HOHalina M. Onishko
Halina M. Onishko
CNChristopher E E Nelson
Christopher E E Nelson
TGTodd Giorgio
Todd Giorgio

1 February 2012 in International Journal of Nanomedicine
Verified
Journal Article
Open access
SYShann S Yu
Shann S Yu
CLCheryl M Lau
Cheryl M Lau
STSusan N Thomas
Susan N Thomas
WJW Gray Jerome
W Gray Jerome
DMDavid J Maron
David J Maron
TGTodd Giorgio
Todd Giorgio
Peer reviewed article authored by (Yu SS, Lau CM, Thomas SN, Jerome WG, Maron DJ, Dickerson JH, Hubbell JA, Giorgio TD). Read article or submit your manuscript for publishing.

1 January 2003 in Cancer Cell
Verified
Journal Article
Closed access
DHDennis Hallahan
Dennis Hallahan
LGLing Geng
Ling Geng
SQShimian Qu
Shimian Qu
CSChristopher Scarfone
Christopher Scarfone
TGTodd Giorgio
Todd Giorgio
JCJeff Clanton
Jeff Clanton

6 February 2013 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
HLHongmei Li
Hongmei Li
SYShann S. Yu
Shann S. Yu
MMMartina Miteva
Martina Miteva
CNChristopher E E Nelson
Christopher E E Nelson
TWThomas Werfel
Thomas Werfel
CDCraig Duvall
Craig Duvall

1 April 2000 in Molecular Therapy
Verified
Journal Article
Open access
MJMolly B. James
Molly B. James
TGTodd Giorgio
Todd Giorgio
Mt is a cross-disciplinary biomedical journal devoted to publishing the most exciting advances in pharmacology and therapeutics, as they pertain to advances in translational and clinical medicine. It is recognized as one of the most prestigious journals in the field. With an impact factor of 6.825*, mt ranks in the top 4.2% of scientific journals in the latest Science Citation Index. Published monthly online and in print.